| Safeway Pharmacy #2999 | |
| 1735 W Main Street, Bozeman, Montana 59715 | |
| (406) 585-9155 |
| Name | Safeway Pharmacy #2999 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 1735 W Main Street, Bozeman, Montana 59715 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 585-9155 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A treatment for neuroblastoma that lands a one-two punch works best when the second punch is timed to take maximum advantage of the first one, according to results of studies at St. Jude Children's Research Hospital.
The state of Michigan, which used a five-step checklist developed at Johns Hopkins to virtually eliminate bloodstream infections in its hospitals' intensive care units , has been able to keep the number of these common, costly and potentially lethal infections near zero - even three years after first adopting the standardized procedures.
At some point you may have had a reaction to penicillin and were told you were allergic. And there's a good chance it has stayed in your chart throughout your childhood and into adulthood.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
In a small village in West Bengal, India, 7-month-old Anwesha is oblivious to the fact that in her community, for generations before her, many newborns did not even live to see their first birthday. In an age old tradition, the community believed that the survival of the newborn or the mother is pre-determined and no extra care or immunization should interfere with the inevitable. It was only after persistent effort by CRY-supported project SSDC for a decade that the attitude of the community began to change.
› Verified 4 days ago
| NPI Number | 1922037944 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #2999 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1735 W Main St, Bozeman, MT 59715 |
| Phone Number | 406-585-9155 |
News Archive
A treatment for neuroblastoma that lands a one-two punch works best when the second punch is timed to take maximum advantage of the first one, according to results of studies at St. Jude Children's Research Hospital.
The state of Michigan, which used a five-step checklist developed at Johns Hopkins to virtually eliminate bloodstream infections in its hospitals' intensive care units , has been able to keep the number of these common, costly and potentially lethal infections near zero - even three years after first adopting the standardized procedures.
At some point you may have had a reaction to penicillin and were told you were allergic. And there's a good chance it has stayed in your chart throughout your childhood and into adulthood.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
In a small village in West Bengal, India, 7-month-old Anwesha is oblivious to the fact that in her community, for generations before her, many newborns did not even live to see their first birthday. In an age old tradition, the community believed that the survival of the newborn or the mother is pre-determined and no extra care or immunization should interfere with the inevitable. It was only after persistent effort by CRY-supported project SSDC for a decade that the attitude of the community began to change.
› Verified 4 days ago
News Archive
A treatment for neuroblastoma that lands a one-two punch works best when the second punch is timed to take maximum advantage of the first one, according to results of studies at St. Jude Children's Research Hospital.
The state of Michigan, which used a five-step checklist developed at Johns Hopkins to virtually eliminate bloodstream infections in its hospitals' intensive care units , has been able to keep the number of these common, costly and potentially lethal infections near zero - even three years after first adopting the standardized procedures.
At some point you may have had a reaction to penicillin and were told you were allergic. And there's a good chance it has stayed in your chart throughout your childhood and into adulthood.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
In a small village in West Bengal, India, 7-month-old Anwesha is oblivious to the fact that in her community, for generations before her, many newborns did not even live to see their first birthday. In an age old tradition, the community believed that the survival of the newborn or the mother is pre-determined and no extra care or immunization should interfere with the inevitable. It was only after persistent effort by CRY-supported project SSDC for a decade that the attitude of the community began to change.
› Verified 4 days ago
Cvs Pharmacy #08621 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 115 North 19th Avenue, Bozeman, Montana 59718 Phone: (406) 587-9252 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 114 Bridger Center Dr, Bozeman, Montana 59715 Phone: (406) 586-1262 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 28a Pronghorn Trl, Bozeman, Montana 59718 Phone: (406) 585-5582 | |
Walmart Pharmacy 10-2084 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1500 N 7th Ave, Bozeman, Montana 59715 Phone: (406) 585-8753 | |
Safeway Pharmacy #2999 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1735 W Main Street, Bozeman, Montana 59715 Phone: (406) 585-9155 |